bioRxiv · 10.1101/2022.06.15.495325
T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies
Abstract
T cells are potent at eliminating pathogens and playing a crucial role in the adaptive immune response. T cell receptor (TCR) convergence describes T cells that share identical TCRs with the same amino acid sequences but have different DNA sequences due to codon degeneracy. We conducted a systematic investigation of TCR convergence using single-cell immune profiling and bulk TCR{beta}-sequence (TCR-seq) data obtained from both mouse and human samples, and uncovered a strong link between antigen-specificity and convergence. This association was stronger than T cell expansion, a putative indicator of antigen-specific T cells. By using flow sorted tetramer+ single T cell data, we discovered that convergent T cells were enriched for a neoantigen-specific CD8+ effector phenotype in the tumor microenvironment. Moreover, TCR convergence demonstrated better prediction accuracy for immunotherapy response than the existing TCR repertoire indexes. In conclusion, convergent T cells are likely to be antigen-specific and might be a novel prognostic biomarker for anti-cancer immunotherapy.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Pan, M. Y., Li, B.. 2022-06-16. T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies. https://doi.org/10.1101/2022.06.15.495325
Cite the original work for its findings. Save a collection to share your selection of sources.